Correlation Between Pfizer and 02005NBN9
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and ALLY 47, you can compare the effects of market volatilities on Pfizer and 02005NBN9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 02005NBN9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 02005NBN9.
Diversification Opportunities for Pfizer and 02005NBN9
Excellent diversification
The 3 months correlation between Pfizer and 02005NBN9 is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ALLY 47 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 02005NBN9 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 02005NBN9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 02005NBN9 has no effect on the direction of Pfizer i.e., Pfizer and 02005NBN9 go up and down completely randomly.
Pair Corralation between Pfizer and 02005NBN9
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.49 times more return on investment than 02005NBN9. However, Pfizer Inc is 2.04 times less risky than 02005NBN9. It trades about -0.01 of its potential returns per unit of risk. ALLY 47 is currently generating about -0.08 per unit of risk. If you would invest 2,694 in Pfizer Inc on October 7, 2024 and sell it today you would lose (35.00) from holding Pfizer Inc or give up 1.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 97.56% |
Values | Daily Returns |
Pfizer Inc vs. ALLY 47
Performance |
Timeline |
Pfizer Inc |
02005NBN9 |
Pfizer and 02005NBN9 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and 02005NBN9
The main advantage of trading using opposite Pfizer and 02005NBN9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 02005NBN9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 02005NBN9 will offset losses from the drop in 02005NBN9's long position.Pfizer vs. Capricor Therapeutics | Pfizer vs. Akari Therapeutics PLC | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings |
02005NBN9 vs. Logan Ridge Finance | 02005NBN9 vs. TPG Inc | 02005NBN9 vs. Alta Equipment Group | 02005NBN9 vs. Carlyle Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Correlations Find global opportunities by holding instruments from different markets |